CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.

Konev AA, Kharitonov AV, Rozov FN, Altshuler EP, Serebryanaya DV, Lassus J, Harjola VP, Katrukha AG, Postnikov AB

Open source

DOI
10.1002/ehf2.12590
Published
2020 Apr
Container
ESC heart failure
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.12590,
  title = {CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.},
  author = {Konev AA and Kharitonov AV and Rozov FN and Altshuler EP and Serebryanaya DV and Lassus J and Harjola VP and Katrukha AG and Postnikov AB},
  year = {2020},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.12590},
  url = {https://doi.org/10.1002/ehf2.12590}
}

RIS

TY  - JOUR
TI  - CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
AU  - Konev AA
AU  - Kharitonov AV
AU  - Rozov FN
AU  - Altshuler EP
AU  - Serebryanaya DV
AU  - Lassus J
AU  - Harjola VP
AU  - Katrukha AG
AU  - Postnikov AB
PY  - 2020
JO  - ESC heart failure
DO  - 10.1002/ehf2.12590
UR  - https://doi.org/10.1002/ehf2.12590
ER  - 

APA

AA, K., AV, K., FN, R., EP, A., DV, S., J, L., VP, H., AG, K., & AB, P. (2020). CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.. ESC heart failure. https://doi.org/10.1002/ehf2.12590

Source records